Clinical Trial Update: A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluated a new MiraLax dose formulation for treating constipation in children and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

Sponsor: Braintree Laboratories | Conditions: Constipation | Phase 4 | Status: COMPLETED